"bms" の関連情報検索結果

Harbour BioMed inks license deal with BMS - The Pharma Letter



Harbour BioMed inks license deal with BMS  The Pharma Letter

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...



Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B  Fierce Biotech

Champions in Care - Bristol Myers Squibb



Champions in Care  Bristol Myers Squibb

Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myer...



Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies  PR Newswire

Harbour Biomed closes busy year with $1B+ BMS deal - BioWorld MedTech



Harbour Biomed closes busy year with $1B+ BMS deal  BioWorld MedTech

Harbour BioMed and BMS sign multi-specific antibody collab - Pharmaceutical Technology



Harbour BioMed and BMS sign multi-specific antibody collab  Pharmaceutical Technology

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace



BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour  BioSpace

BMS Jumps Aboard Harbour’s R&D Ship - Citeline News & Insights



BMS Jumps Aboard Harbour’s R&D Ship  Citeline News & Insights

BMS strikes $1.1B multispecific antibody pact with Harbour - FirstWord Pharma



BMS strikes $1.1B multispecific antibody pact with Harbour  FirstWord Pharma

Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies - Contract Pharma



Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies  Contract Pharma

The evolution of wireless BMS in EVs and high-voltage systems - EVreporter •



The evolution of wireless BMS in EVs and high-voltage systems  EVreporter •

Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology - TipRanks



Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology  TipRanks

BioNTech and BMS’ bispecific touts 59.3% nine-month PFS in TNBC - Clinical Trials Arena



BioNTech and BMS’ bispecific touts 59.3% nine-month PFS in TNBC  Clinical Trials Arena

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...



With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis  Fierce Pharma

BMS tickets on sale at Food City locations - Kingsport Times News



BMS tickets on sale at Food City locations  Kingsport Times News

BMS sets India entry via Berns Brett partnership - Insurance Business



BMS sets India entry via Berns Brett partnership  Insurance Business

Building a healthier future together: Strengthening cancer care across Africa through partnership...



Building a healthier future together: Strengthening cancer care across Africa through partnership  Bristol Myers Squibb

Backed by J&J and BMS, Link Cell debuts with logic-gated CAR-T playbook - FirstWord Pharma



Backed by J&J and BMS, Link Cell debuts with logic-gated CAR-T playbook  FirstWord Pharma

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace



BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study  BioSpace

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...



Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)  Bristol Myers Squibb

CAR T cell therapy patient resources - Bristol Myers Squibb



CAR T cell therapy patient resources  Bristol Myers Squibb

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 20...



Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025  ts2.tech

Global Inclusion - Bristol Myers Squibb



Global Inclusion  Bristol Myers Squibb

Become a business supplier - Bristol Myers Squibb



Become a business supplier  Bristol Myers Squibb

Global Patient Week - Bristol Myers Squibb



Global Patient Week  Bristol Myers Squibb

Independent research - Bristol Myers Squibb



Independent research  Bristol Myers Squibb

About us - Bristol Myers Squibb



About us  Bristol Myers Squibb

Business development leadership team - Bristol Myers Squibb



Business development leadership team  Bristol Myers Squibb

Why Bristol-Myers Squibb (BMY) Stock Is Up Today - Yahoo Finance



Why Bristol-Myers Squibb (BMY) Stock Is Up Today  Yahoo Finance

Merck, Bristol Myers Squibb plan NJ layoffs (updated) - NJBIZ



Merck, Bristol Myers Squibb plan NJ layoffs (updated)  NJBIZ

BMS strengthens MENA and India presence with DIFC launch and new partnership - Intelligent Insurer



BMS strengthens MENA and India presence with DIFC launch and new partnership  Intelligent Insurer

Bristol Myers Squibb donates $32K to fund lab equipment for charter school - ROI-NJ



Bristol Myers Squibb donates $32K to fund lab equipment for charter school  ROI-NJ

Chris Shibutani, MD - Bristol Myers Squibb



Chris Shibutani, MD  Bristol Myers Squibb

Our technologies - Bristol Myers Squibb



Our technologies  Bristol Myers Squibb

Transparency & reporting - Bristol Myers Squibb



Transparency & reporting  Bristol Myers Squibb

APMT, BMS sign Apapa lease through 2031 - Port Technology



APMT, BMS sign Apapa lease through 2031  Port Technology

By the Numbers: Food City Speedway in Lights at Bristol Motor Speedway - Speedway Digest



By the Numbers: Food City Speedway in Lights at Bristol Motor Speedway  Speedway Digest

Our research in neuroscience - Bristol Myers Squibb



Our research in neuroscience  Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb



Empowering patients with clarity & confidence through UPL program  Bristol Myers Squibb

BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” - Clinical Trials Arena



BMS delays Alzheimer’s readout for Cobenfy over “site irregularities”  Clinical Trials Arena

BMS Group expands in India with Berns Brett partnership - theinsurer.com



BMS Group expands in India with Berns Brett partnership  theinsurer.com

The Bristol Myers Squibb Foundation - Bristol Myers Squibb



The Bristol Myers Squibb Foundation  Bristol Myers Squibb

BMS Group Announces Further Expansion - - Insurance Edge



BMS Group Announces Further Expansion -  Insurance Edge

Driving patient-centric care through global patient outreach - Bristol Myers Squibb



Driving patient-centric care through global patient outreach  Bristol Myers Squibb

Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies - ge...



Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies  geneonline.com

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...



Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients  Bain Capital

Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules - Reuters



Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules  Reuters

Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing - Fierce Pharma



Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing  Fierce Pharma

Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb



Science Firsthand: The renaissance of neuroscience R&D  Bristol Myers Squibb

Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking ...



Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it?  Bristol Myers Squibb

Areas of interest - Bristol Myers Squibb



Areas of interest  Bristol Myers Squibb

RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb



RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs  Bristol Myers Squibb

Privacy notice center - Bristol Myers Squibb



Privacy notice center  Bristol Myers Squibb

Bristol Myers Squibb, Accenture launch AI-powered content hub ‘Mosaic’ in Mumbai - ETPharma.com



Bristol Myers Squibb, Accenture launch AI-powered content hub ‘Mosaic’ in Mumbai  ETPharma.com

People and business resource groups - Bristol Myers Squibb



People and business resource groups  Bristol Myers Squibb

BMS launches in the DIFC as regional expansion continues - Global Reinsurance



BMS launches in the DIFC as regional expansion continues  Global Reinsurance

BMS Group Forms Partnership With Berns Brett India - - Insurance Edge



BMS Group Forms Partnership With Berns Brett India -  Insurance Edge

Cambridge biotech receives $255M in sale of spinout to BMS - The Business Journals



Cambridge biotech receives $255M in sale of spinout to BMS  The Business Journals

Why RV Energy Storage Lithium Batteries Cut Out After Bumps? BMS - openPR.com



Why RV Energy Storage Lithium Batteries Cut Out After Bumps? BMS  openPR.com

FDA Fast Tracks Anti-MTBR-Tau-Targeting Antibody BMS-986446 for Alzheimer Disease - NeurologyLive



FDA Fast Tracks Anti-MTBR-Tau-Targeting Antibody BMS-986446 for Alzheimer Disease  NeurologyLive

Clinical trials & studies - Bristol Myers Squibb



Clinical trials & studies  Bristol Myers Squibb

From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer - Bristol Myers Squibb



From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer  Bristol Myers Squibb

Accenture helps Bristol Myers Squibb to launch AI-based medical content hub Mosaic - Times of India



Accenture helps Bristol Myers Squibb to launch AI-based medical content hub Mosaic  Times of India

Psoriasis around the world - Bristol Myers Squibb



Psoriasis around the world  Bristol Myers Squibb

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace



BMS Makes $1.5B Cell Therapy Play With Orbital Takeover  BioSpace

Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent ...



Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan  Fortune

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...



BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future  Fierce Biotech

BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes - Fierce Biotech



BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes  Fierce Biotech

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...



BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia  Fierce Biotech

300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...



300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C  Bristol Myers Squibb

Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma



Merck & Co., BMS to lay off over 300 staffers in New Jersey  FirstWord Pharma

Our science - Bristol Myers Squibb



Our science  Bristol Myers Squibb

Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb



Nurse practitioners impact patient care and foster collaboration  Bristol Myers Squibb

FDA Action Alert: BMS, GSK, Amgen and More - BioSpace



FDA Action Alert: BMS, GSK, Amgen and More  BioSpace

Honoring oncologists through the Time Back campaign - Bristol Myers Squibb



Honoring oncologists through the Time Back campaign  Bristol Myers Squibb

Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva



Bristol Myers Squibb Commits to Veeva Vault CRM  Veeva

Worldwide locations - Bristol Myers Squibb



Worldwide locations  Bristol Myers Squibb

Internship insights: ‘Show initiative and lean into areas that spark interest’ - Silicon Republic



Internship insights: ‘Show initiative and lean into areas that spark interest’  Silicon Republic

Pre-approval access to investigational medicines - Bristol Myers Squibb



Pre-approval access to investigational medicines  Bristol Myers Squibb

A global journey through BMS’ R&D hubs - Bristol Myers Squibb



A global journey through BMS’ R&D hubs  Bristol Myers Squibb

BMS Strengthens Global Leadership with Cutting-Edge Roll Forming Machinery Solutions - FinancialC...



BMS Strengthens Global Leadership with Cutting-Edge Roll Forming Machinery Solutions  FinancialContent

Our impact - Bristol Myers Squibb



Our impact  Bristol Myers Squibb

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative ...



Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection  Bristol Myers Squibb

BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology



BMS expands CAR-T portfolio with $1.5bn Orbital buyout  Pharmaceutical Technology

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace



BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line  BioSpace

BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma



BMS to close Illinois site as part of cell therapy manufacturing consolidation  FirstWord Pharma

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...



ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial  Fierce Biotech

Bristol-Myers Squibb (BMY) Stock News Today: BofA Upgrade, Dividend Momentum and 2026 Pipeline Ca...



Bristol-Myers Squibb (BMY) Stock News Today: BofA Upgrade, Dividend Momentum and 2026 Pipeline Catalysts in Focus (Dec. 16, 2025)  ts2.tech

BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise - Yahoo Finance



BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise  Yahoo Finance

I-See-BMs: Chinese Nuclear Policy Under Xi Jinping - Foreign Policy Research Institute



I-See-BMs: Chinese Nuclear Policy Under Xi Jinping  Foreign Policy Research Institute

BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...



BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future  Fierce Pharma

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace



BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC  BioSpace

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...



BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients  Fierce Pharma

Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb



Doctorx Unscripted Bold Conversations about Patient-Driven Science  Bristol Myers Squibb

"Too many patients in rural America face barriers to cardiovascular care — barriers that - Bristo...



"Too many patients in rural America face barriers to cardiovascular care — barriers that  Bristol Myers Squibb

Looking to the Future of Cell Therapy - Bristol Myers Squibb



Looking to the Future of Cell Therapy  Bristol Myers Squibb

2025 Annual Meeting of Shareholders - Bristol Myers Squibb



2025 Annual Meeting of Shareholders  Bristol Myers Squibb

Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS - Kaseya



Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS  Kaseya

BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma



BMS, Pfizer launch direct-to-consumer push for Eliquis in the US  FirstWord Pharma

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech



BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence  Fierce Biotech